Oncology Treatment and Products

The company has established cooperative relations with many research institutes and is committed to the promotion of cancer stem cell products. The scientific research institutions cooperating with the company focus on NF-κBas the target, and through screening, it is found that FK0021 has significant anti-tumor activity, which can inhibit the NF-κB activity of cancer stem cells, thus killing cancer stem cells, and has a strong inhibitory effect on the proliferation and growth of human tumor cells such as breast cancer, lymphoma, liver cancer, lung cancer and leukemia. It can reverse the multidrug resistance of tumors, reduce the risk of recurrence, and has low toxicity and no mutagenic toxicity.

Tumor Adjuvant Therapy Devices-Nano Transdermal Products

Tumor Stem Cell Pharmacy Products - Nebulized Lung Permeation Products

Tumor Stem Cell Therapy Drugs